We found a significant positive correlation between the expression of several DRGs (RPN1, GYS1) and StromalScore (Figure 3A), ImmuneScore (Figure 3B), and ESTIMATEScore (Figure 3C) in glioma. Here, GYS1 is linked to central nervous system cancer.